Serna, R. d. A. A. Et Al. 2022. COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSES OF IMPLEMENTING THE FIRST PILLAR OF PATIENT BLOOD MANAGEMENT, WITH INTRAVENOUS (IV) FERRIC CARBOXYMALTOSE (FCM), ON THE TURKISH HEALTHCARE SYSTEM. VALUE IN HEALTH , no.12 .

Serna, R. d. A. A., Tatar, M., Alkins, N., YILDIRIM GÜÇLÜ, Ç., BERMEDE, A. O., Erdemli, V., ... Gunaydin, S.(2022). COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSES OF IMPLEMENTING THE FIRST PILLAR OF PATIENT BLOOD MANAGEMENT, WITH INTRAVENOUS (IV) FERRIC CARBOXYMALTOSE (FCM), ON THE TURKISH HEALTHCARE SYSTEM. VALUE IN HEALTH , no.12.

Serna, Ramirez Et Al. "COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSES OF IMPLEMENTING THE FIRST PILLAR OF PATIENT BLOOD MANAGEMENT, WITH INTRAVENOUS (IV) FERRIC CARBOXYMALTOSE (FCM), ON THE TURKISH HEALTHCARE SYSTEM," VALUE IN HEALTH , no.12, 2022

Serna, Ramirez d. Et Al. "COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSES OF IMPLEMENTING THE FIRST PILLAR OF PATIENT BLOOD MANAGEMENT, WITH INTRAVENOUS (IV) FERRIC CARBOXYMALTOSE (FCM), ON THE TURKISH HEALTHCARE SYSTEM." VALUE IN HEALTH , no.12, 2022

Serna, R. d. A. A. Et Al. (2022) . "COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSES OF IMPLEMENTING THE FIRST PILLAR OF PATIENT BLOOD MANAGEMENT, WITH INTRAVENOUS (IV) FERRIC CARBOXYMALTOSE (FCM), ON THE TURKISH HEALTHCARE SYSTEM." VALUE IN HEALTH , no.12.

@article{article, author={Ramirez de Arellano A. Serna Et Al. }, title={COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSES OF IMPLEMENTING THE FIRST PILLAR OF PATIENT BLOOD MANAGEMENT, WITH INTRAVENOUS (IV) FERRIC CARBOXYMALTOSE (FCM), ON THE TURKISH HEALTHCARE SYSTEM}, journal={VALUE IN HEALTH}, year=2022}